IPO Calendar
Data supplied by IPOScoop.com
| Ticker | Company | Company lead managers | Shares | Estimated volume | Expected trade date |
|---|---|---|---|---|---|
| SNNA | Sienna Biopharmaceuticals | J.P. Morgan/ Cowen/ BMO Capital Markets | 4.33 Million | 65 Million | 07/26/2017 |
| CMTA | Clementia Pharmaceuticals | Morgan Stanley/ Leerink Partners | 7.15 Million | 100.1 Million | 07/26/2017 |
Historical IPO Database
Last 62 IPO's
| index | Ticker | Company | IPO price | Price after first day | Current price | Return | Offer date |
|---|---|---|---|---|---|---|---|
| 1 | PETQ | PetIQ | N/A | N/A | N/A | 36.75% | 07/26/2017 |
| 2 | KALA | Kala Pharmaceuticals | N/A | N/A | N/A | 28% | 07/26/2017 |
| 3 | AKCA | Akcea Therapeutics | N/A | N/A | N/A | 72.13% | 07/26/2017 |
| 4 | CODX | Co-Diagnostics | N/A | N/A | N/A | -21.67% | 07/26/2017 |
| 5 | ALRN | Aileron Therapeutics | N/A | N/A | N/A | -13.33% | 07/26/2017 |
| 6 | DOVA | Dova Pharmaceuticals | N/A | N/A | N/A | 25.47% | 07/26/2017 |
| 7 | MRSN | Mersana Therapeutics | N/A | N/A | N/A | 0.07% | 07/26/2017 |
| 8 | ATXI | Avenue Therapeutics | N/A | N/A | N/A | 16.83% | 07/26/2017 |
| 9 | ATNX | Athenex | N/A | N/A | N/A | 68.64% | 07/26/2017 |
| 10 | IMRN | Immuron Ltd (stock) | N/A | N/A | N/A | -36.74% | 07/26/2017 |
| 11 | IMRNW | Immuron Ltd (warrants) | N/A | N/A | N/A | 0% | 07/26/2017 |
| 12 | ARGX | argenx SE | N/A | N/A | N/A | 35.29% | 07/26/2017 |
| 13 | GTHX | G1 Therapeutics | N/A | N/A | N/A | 0.07% | 07/26/2017 |
| 14 | OVID | Ovid Therapeutics | N/A | N/A | N/A | -40.93% | 07/26/2017 |
| 15 | URGN | UroGen Pharma Ltd. | N/A | N/A | N/A | 46.08% | 07/26/2017 |
| 16 | BOLT | BioLight Life Sciences Ltd. | N/A | N/A | N/A | 0% | 07/26/2017 |
| 17 | BHVN | Biohaven Pharmaceutical Holding | N/A | N/A | N/A | 54.29% | 07/26/2017 |
| 18 | ZYME | Zymeworks | N/A | N/A | N/A | -43.92% | 07/26/2017 |
| 19 | VRNA | Verona Pharma plc | N/A | N/A | N/A | 0% | 07/26/2017 |
| 20 | TOCA | Tocagen | N/A | N/A | N/A | 11.6% | 07/26/2017 |
| 21 | VLRX | Valeritas Holdings | N/A | N/A | N/A | -28.8% | 07/26/2017 |
| 22 | BYSI | BeyondSpring | N/A | N/A | N/A | 98.5% | 07/26/2017 |
| 23 | JNCE | Jounce Therapeutics | N/A | N/A | N/A | -17% | 07/26/2017 |
| 24 | ANAB | AnaptysBio | N/A | N/A | N/A | 86% | 07/26/2017 |
| 25 | OBSV | ObsEva SA | N/A | N/A | N/A | -46.87% | 07/26/2017 |
| 26 | MYOV | Myovant Sciences Ltd. | N/A | N/A | N/A | -21.87% | 07/26/2017 |
| 27 | RARX | Ra Pharmaceuticals | N/A | N/A | N/A | 17.38% | 07/26/2017 |
| 28 | IRTC | iRhythm Technologies | N/A | N/A | N/A | 149.88% | 07/26/2017 |
| 29 | CRSP | CRISPR Therapeutics AG | N/A | N/A | N/A | 24.93% | 07/26/2017 |
| 30 | AZRX | AzurRx BioPharma | N/A | N/A | N/A | -16.36% | 07/26/2017 |
| 31 | OBLN | Obalon Therapeutics | N/A | N/A | N/A | -41.4% | 07/26/2017 |
| 32 | FLGT | Fulgent Genetics | N/A | N/A | N/A | -27.44% | 07/26/2017 |
| 33 | ACIU | AC Immune SA | N/A | N/A | N/A | -26.45% | 07/26/2017 |
| 34 | NOVN | Novan | N/A | N/A | N/A | -63.27% | 07/26/2017 |
| 35 | MEDP | Medpace Holdings | N/A | N/A | N/A | 24.52% | 07/26/2017 |
| 36 | PTGX | Protagonist Therapeutics | N/A | N/A | N/A | 10.33% | 07/26/2017 |
| 37 | GEMP | Gemphire Therapeutics | N/A | N/A | N/A | 87% | 07/26/2017 |
| 38 | TCMD | Tactile Systems Technology | N/A | N/A | N/A | 203.9% | 07/26/2017 |
| 39 | KDMN | Kadmon Holdings | N/A | N/A | N/A | -77.33% | 07/26/2017 |
| 40 | PTHN | Patheon N.V. | N/A | N/A | N/A | 66.62% | 07/26/2017 |
| 41 | BOLD | Audentes Therapeutics | N/A | N/A | N/A | 47.33% | 07/26/2017 |
| 42 | SYRS | Syros Pharmaceuticals | N/A | N/A | N/A | 77.12% | 07/26/2017 |
| 43 | SELB | Selecta Biosciences | N/A | N/A | N/A | 27.71% | 07/26/2017 |
| 44 | CLSD | Clearside Biomedical | N/A | N/A | N/A | 32.86% | 07/26/2017 |
| 45 | RETA | Reata Pharmaceuticals | N/A | N/A | N/A | 195.64% | 07/26/2017 |
| 46 | MRUS | Merus B.V. | N/A | N/A | N/A | 68.3% | 07/26/2017 |
| 47 | PLSE | Pulse Biosciences | N/A | N/A | N/A | 593.75% | 07/26/2017 |
| 48 | PZRX | PhaseRx | N/A | N/A | N/A | -84.6% | 07/26/2017 |
| 49 | ONSIU | Oncobiologics | N/A | N/A | N/A | -23% | 07/26/2017 |
| 50 | NTLA | Intellia Therapeutics | N/A | N/A | N/A | -6.06% | 07/26/2017 |
| 51 | SBPH | Spring Bank Pharmaceuticals | N/A | N/A | N/A | 17.25% | 07/26/2017 |
| 52 | ARA | American Renal Associates Holdings | N/A | N/A | N/A | -18.23% | 07/26/2017 |
| 53 | AGLE | Aeglea BioTherapeutics | N/A | N/A | N/A | -63.8% | 07/26/2017 |
| 54 | CRVS | Corvus Pharmaceuticals | N/A | N/A | N/A | -18.87% | 07/26/2017 |
| 55 | SNDX | Syndax Pharmaceuticals | N/A | N/A | N/A | 12.08% | 07/26/2017 |
| 56 | AVXS | AveXis | N/A | N/A | N/A | 341.3% | 07/26/2017 |
| 57 | PTI | Proteostasis Therapeutics | N/A | N/A | N/A | -56.88% | 07/26/2017 |
| 58 | BGNE | BeiGene, Ltd. | N/A | N/A | N/A | 190% | 07/26/2017 |
| 59 | EDIT | Editas Medicine | N/A | N/A | N/A | 1.94% | 07/26/2017 |
| 60 | AXSM | Axsome Therapeutics | N/A | N/A | N/A | -36.67% | 07/26/2017 |
| 61 | AAAP | Advanced Accelerator Applications S.A. | N/A | N/A | N/A | 161.56% | 07/26/2017 |
| 62 | GI | EndoChoice Holdings (ECPM Holdings) | N/A | N/A | N/A | -46.67% | 07/26/2017 |